Publications by authors named "Umberto Vitolo"

100Publications

Chemotherapy combinations for B-cell lymphoma and chemo-free approach in elderly patients: an update on best practice.

Expert Rev Hematol 2020 Aug 1;13(8):851-869. Epub 2020 Aug 1.

Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS , Candiolo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2020.1796623DOI Listing
August 2020

Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?

Hemasphere 2019 Oct 31;3(5):e284. Epub 2019 Jul 31.

Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919463PMC
October 2019

Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence.

Expert Rev Hematol 2019 09 8;12(9):787-796. Epub 2019 Aug 8.

Hematology, Città della Salute e della Scienza Hospital and University , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1643232DOI Listing
September 2019

High-grade B-cell lymphoma: how to diagnose and treat.

Expert Rev Hematol 2019 07 19;12(7):497-506. Epub 2019 Jun 19.

a Hematology , Città della Salute e della Scienza Hospital and University , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1624157DOI Listing
July 2019

Monoclonal antibody-drug conjugates in B-cell lymphomas.

Lancet Haematol 2019 May 29;6(5):e232-e233. Epub 2019 Mar 29.

Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino 10126, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30048-1DOI Listing
May 2019

Histological transformation and secondary malignancies in follicular lymphoma.

Lancet Haematol 2018 Nov;5(11):e496-e497

Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, 10126 Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30170-4DOI Listing
November 2018

Brentuximab vedotin-based salvage treatment in Hodgkin's lymphoma.

Lancet Oncol 2018 09 16;19(9):1144-1146. Epub 2018 Aug 16.

Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Corso Bramante 88, 10126 Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30510-2DOI Listing
September 2018

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

J Clin Oncol 2018 08 31;36(23):2405-2412. Epub 2018 May 31.

Ajay K. Gopal, The University of Washington; Ajay K. Gopal, Fred Hutchinson Cancer Research Center, Seattle, WA; Stephen J. Schuster, Abramson Cancer Center of the University of Pennsylvania, Philadelphia; Jing-Zhou Hou, University of Pittsburgh Medical Center; Jing-Zhou Hou, University of Pittsburgh Cancer Institute, Pittsburgh; Rajendra N. Damle, Michael Schaffer, and Sriram Balasubramanian, Janssen Research & Development, Spring House, PA; Nathan H. Fowler, The University of Texas MD Anderson Cancer Center, Houston, TX; Judith Trotman, Concord Hospital, University of Sydney, Sydney, New South Wales; Andrew Spencer, Alfred Hospital-Monash University, Melbourne, Victoria; James Morton, Haematology and Oncology Clinics of Australia, Milton, Queensland, Australia; Georg Hess, Johannes Gutenberg-University, Mainz, Germany; Abdulraheem Yacoub, Kansas University Medical Center, Kansas City, KS; Michael Lill, Cedars-Sinai Medical Center, Los Angeles, CA; Peter Martin, Weill Cornell Medical College, Cornell University, New York, NY; Umberto Vitolo, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy; John Radford, University of Manchester; John Radford, Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Wojciech Jurczak, Jagiellonian University, Kraków, Poland; Dolores Caballero, Hospital Clínico Universitario, Salamanca, Spain; Sanjay Deshpande, Gary J. Gartenberg, and Shean-Sheng Wang, Janssen Research & Development, Raritan, NJ; Jessica Vermeulen, Janssen Research & Development, Leiden, the Netherlands; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; and Gilles Salles, Hospices Civils de Lyon-Université de Lyon, Pierre-Bénite cedex, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8853DOI Listing
August 2018

Salvage regimens for Hodgkin's lymphoma in the brentuximab vedotin era.

Lancet Oncol 2018 02 21;19(2):162-163. Epub 2017 Dec 21.

Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, 10126 Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30913-0DOI Listing
February 2018

A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma.

Br J Haematol 2018 12 19;183(5):828-831. Epub 2017 Dec 19.

Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15057DOI Listing
December 2018

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma.

J Clin Oncol 2018 03 2;36(7):689-696. Epub 2017 Nov 2.

Stefano Luminari, Angela Ferrari, and Francesco Merli, Azienda Ospedaliera Arcispedale Santa Maria Nuova-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia; Stefano Luminari, Martina Manni, Alessandra Dondi, Vittoria Tarantino, Luigi Marcheselli, and Massimo Federico, University of Modena and Reggio Emilia, Modena, Italy; Annalisa Chiarenza, Azienda Ospedaliera Universitaria Policlinico-Vittorio Emanuele, University of Catania, Catania; Chiara Rusconi, Azienda Socio Sanitaria Territoriale (ASST) -Grande Ospedale Metropolitano Niguarda; Andrés J.M. Ferreri, IRCCS San Raffaele Scientific Institute, Milano; Alessandra Tucci, ASST-Spedali Civili di Brescia, Brescia; Umberto Vitolo, Città della Salute e della Scienza University and Hospital, Torino; Sofia Kovalchuk, University of Florence, Florence; Emanuele Angelucci, Ospedale Policlinico San Martino, Genova; Alessandro Pulsoni, Sapienza University of Rome, Rome; Luca Arcaini, Fondazione IRCCS Policlinico San Matteo, Pavia; Francesco Angrilli, Spirito Santo Hospital, Pescara; Gianluca Gaidano, University of Eastern Piedmont, Novara; Caterina Stelitano, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria; Giovanni Bertoldero, Ospedale di Mirano, Mirano; Nicola Cascavilla, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo; Flavia Salvi, Ospedale SS Antonio e Biagio, Alessandria; and Daniele Vallisa, Guglielmo da Saliceto Hospital, Piacenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1652DOI Listing
March 2018

Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma - Authors' reply.

Lancet Oncol 2017 10;18(10):e558

Department of Haematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, 10126 Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30702-7DOI Listing
October 2017

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2017 Nov 10;35(31):3529-3537. Epub 2017 Aug 10.

Umberto Vitolo, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin; Angelo Michele Carella, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera e Universitaria San Martino-IST, Genoa; Antonio Pinto, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples; Maurizio Martelli, Sapienza University, Rome, Italy; Marek Trněný, Charles University, General Hospital, Prague; David Belada, Charles University Hospital, Hradec Králové, Czech Republic; John M. Burke, Rocky Mountain Cancer Centers, Aurora, CO; US Oncology Research, The Woodlands, TX; Neil Chua, Cross Cancer Institute, University of Alberta, Edmonton, Alberta; Laurie H. Sehn, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada; Pau Abrisqueta, University Hospital Vall d'Hebron, Barcelona, Spain; Judit Demeter, Semmelweiss University, Budapest, Hungary; Ian Flinn, Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN; Xiaonan Hong, Fudan University Shanghai Cancer Center, Shanghai; Yuan-Kai Shi, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China; Won Seog Kim, Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, Republic of Korea; Yoichi Tatsumi, Kinki University Hospital, Osaka, Japan; Mikkel Z. Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.3402DOI Listing
November 2017

Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study.

Br J Haematol 2018 08 24;182(3):453-456. Epub 2017 Jul 24.

USI Università della Svizzera Italiana (USI), Institute of Oncology Research (IOR), Bellinzona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14817DOI Listing
August 2018

Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma.

Expert Rev Hematol 2017 08 14;10(8):697-705. Epub 2017 Jul 14.

a Città della Salute e della Scienza Hospital and University , Hematology , Turin , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1350164DOI Listing
August 2017

Current options to manage Waldenström's macroglobulinemia.

Expert Rev Hematol 2017 07 19;10(7):637-647. Epub 2017 Jun 19.

a Division of Hematology , AOU Città della Salute e della Scienza , Torino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1339596DOI Listing
July 2017

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

J Clin Oncol 2017 Jun 29;35(17):1905-1912. Epub 2017 Mar 29.

Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andrés J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia; Umberto Vitolo, University-Hospital Città della Salute e della Scienza, Turin; Maurizio Martelli, Sapienza University; Stefan Hohaus, Catholic University of the Sacred Heart, Rome; Graziella Pinotti, Fondazione Macchi Hospital, Varese; Caterina Stelitano, Bianchi-Melacrino-Morelli Hospitals, Reggio Calabria; Monica Bellei, University of Modena and Reggio Emilia, Modena, Italy; Reda Bouabdallah, Institut Paoli-Calmettes, Marseille; Gilles Salles, Hospices Civils de Lyon and Université Claude Bernard Lyon-1, Pierre-Benite; Catherine Sebban, Centre Léon Bérard, Lyon; Franck Morschhauser, Claude Huriez Hospital, Lille; Anne Moreau, University Hospital of Nantes, Nantes; Hervé Tilly, Centre Henri Becquerel, Rouen; Corinne Haioun, Henri-Mondor Hospital, Paris Créteil; Corinne Haioun, UPEC, Assistance Publique-Hopitaux de Paris; Catherine Thieblemont, Assistance Publique-Hopitaux de Paris, Hôpital-Saint-Louis, Hematooncology-Université Paris Diderot, Sorbonne Paris-Cité, Paris, France; Ruth Pettengell, St George's University of London, London; Andrew Jack, St James's University Hospital, Leeds; Peter Johnson, Southampton General Hospital, Southampton, United Kingdom; Armando Lopez Guillermo and Elias Campo, Hospital Clinic, Barcelona, Spain; Pierre Zachée, ZNA Stuivenberg, Antwerp; and André Bosly, Mont-Godinne UCL, Yvoir, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.6994DOI Listing
June 2017

Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.

Expert Rev Hematol 2017 Apr 27;10(4):289-297. Epub 2017 Mar 27.

a Hematology , Città della Salute e della Scienza Hospital and University , Turin , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/17474086.2017.1
Publisher Site
http://dx.doi.org/10.1080/17474086.2017.1305264DOI Listing
April 2017

Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma.

Future Oncol 2017 04 10;13(10):859-862. Epub 2017 Feb 10.

Divison of Hematology, Città della Salute e della Scienza Hospital & University, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0567DOI Listing
April 2017

Follicular Lymphoma: The Management of Elderly Patient.

Mediterr J Hematol Infect Dis 2017 1;9(1):e2017009. Epub 2017 Jan 1.

Città della Salute e della Scienza University and Hospital, Hematology Unit, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2017.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224805PMC
January 2017

Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.

J Clin Oncol 2017 Feb 28;35(5):552-560. Epub 2016 Dec 28.

Qian Shi and Daniel J. Sargent, Mayo Clinic, Rochester; Bruce A. Peterson, University of Minnesota, Minneapolis, MN; Christopher R. Flowers, Winship Cancer Institute of Emory University, Atlanta, GA; Wolfgang Hiddemann and Eva Hoster, Ludwig-Maximilians University Hospital, Munich; Michael Herold, HELIOS Kliniken, Erfurt, Germany; Robert Marcus, Addenbrooke's Hospital, Cambridge, United Kingdom; Anton Hagenbeek, Academic Medical Center, Amsterdam, the Netherlands; Eva Kimby, Karolinska Institutet, Stockholm, Sweden; Howard Hochster, Yale Cancer Center, New Haven, CT; Umberto Vitolo, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin; Marco Ladetto, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Emmanuel Gyan, University Hospital, Tours; Franck Morschhauser, Service Université de Lille 2, Lille; Gilles Salles, Université Claude Bernard, Pierre Bénite, France; Michele Ghielmini and Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona; Michele Ghielmini and Emanuele Zucca, Swiss Group for Clinical Cancer Research, Bern; Tina Nielsen, F. Hoffmann-La Roche, Basel; Sabine De Bedout, Celgene, Boudry, Switzerland; Tommy Fu, Celgene, Summit, NJ; Nancy Valente, Genentech, South San Francisco, CA; and Nathan H. Fowler, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.8651DOI Listing
February 2017

State-of-the-art Therapy for Advanced-stage Diffuse Large B-cell Lymphoma.

Hematol Oncol Clin North Am 2016 Dec;30(6):1147-1162

Hematology, Città della Salute e della Scienza Hospital and University, corso Bramante 88, Torino 10126, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2016.07.002DOI Listing
December 2016

G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin's lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy.

Med Oncol 2016 Dec 7;33(12):139. Epub 2016 Nov 7.

Dipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Università di Modena e Reggio Emilia, Modena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-016-0850-9DOI Listing
December 2016

Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.

Am J Hematol 2017 Jan 12;92(1):37-41. Epub 2016 Nov 12.

Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Hematology and Clinical Oncology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24572DOI Listing
January 2017

Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy.

Leuk Lymphoma 2016 11 1;57(11):2677-80. Epub 2016 Mar 1.

k Hematology Unit, Department of Oncology and Advanced Technology , Arcispedale Santa Maria Nuova- Istituto Di Ricovero E Cura a Carattere Scientifico , Reggio Emilia , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1153088DOI Listing
November 2016

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

J Clin Oncol 2016 Apr 16;34(12):1376-85. Epub 2016 Feb 16.

Pier Luigi Zinzani, Alessandro Broccoli, and Lisa Argnani, Institute of Hematology L. e A. Seràgnoli, Sant'Orsola-Malpighi University Hospital, Bologna; Daniela Maria Gioia and Alessandro Levis, Fondazione Italiana Linfomi Onlus; Flavia Salvi, S.S. Antonio e Biagio Hospital, Alessandria; Antonio Castagnoli, Azienda Ospedaliera di Prato, Prato; Giovannino Ciccone and Andrea Evangelista, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino and Centro Prevenzione Oncologica Piemonte; Umberto Ricardi, University of Turin; Umberto Vitolo and Patrizia Pregno, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino; Roberto Freilone, Stabilimento Ospitaliero Ivrea, Turin; Armando Santoro, Ercole Brusamolino, and Antonella Anastasia, Istituto Clinico Humanitas; Chiara Rusconi, Azienda Ospedaliera Niguarda Cà Granda, Milan; Maurizio Bonfichi and Ercole Brusamolino, Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo di Pavia, Pavia; Giuseppe Rossi and Antonella Anastasia, Spedali Civili, Brescia; Francesco Zaja, Santa Maria della Misericordia Hospital, Udine; Vincenzo Pavone, Azienda Ospedaliera Cardinal Panico, Tricase; Alessandro Pulsoni, Sapienza University, Rome; Luigi Rigacci, Azienda Ospedaliera Careggi, Florence; Gianluca Gaidano, Amedeo Avogadro University; Gian Mauro Sacchetti, University Hospital Maggiore della Carità, Novara; Caterina Stelitano, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria; Monica Tani, Santa Maria delle Croci Hospital, Ravenna; and Eugenio Borsatti, Centro di Riferimento Oncologico, Aviano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.0699DOI Listing
April 2016

Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly.

Br J Haematol 2016 07 28;174(1):160-2. Epub 2015 Oct 28.

Department of Haematology and Oncology, Città della Salute e della Scienza Hospital, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13758DOI Listing
July 2016

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.

J Mol Diagn 2015 Nov 28;17(6):652-60. Epub 2015 Aug 28.

Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy; Hematology Division, A.O.S. Antonio, Biagio and Cesare Arrigo, Alessandria, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2015.05.007DOI Listing
November 2015

Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper.

Clin Lymphoma Myeloma Leuk 2015 Sep 19;15(9):507-13. Epub 2015 Jun 19.

University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.06.008DOI Listing
September 2015

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

J Clin Oncol 2014 Jun 5;32(17):1769-75. Epub 2014 May 5.

Maurizio Martelli and Erica Finolezzi, Sapienza University, Rome; Pier Luigi Zinzani and Stefano A. Pileri, Policlinico S. Orsola-Malpighi, Bologna; Andrés J.M. Ferreri, San Raffaele Scientific Institute, Milan; Umberto Vitolo, Azienda Ospedaliera S. Giovanni Battista, Torino; Caterina Stelitano, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria; Ercole Brusamolino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia; Maria Giuseppina Cabras, Ospedale Businco, Cagliari; Luigi Rigacci, Policlinico Careggi, Florence; Monica Balzarotti, IRCCS Humanitas, Rozzano; Flavia Salvi, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Luca Ceriani, Emanuele Zucca, Franco Cavalli, and Luca Giovanella, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Silvia Montoto, Barts Cancer Institute, London; Andrew Davies and Peter W.M. Johnson, University of Southampton, Southampton, United Kingdom; and Armando Lopez-Guillermo, Hospital Clinic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.7524DOI Listing
June 2014

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.

Br J Haematol 2014 Jul 27;166(1):69-76. Epub 2014 Mar 27.

Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, AOU Maggiore della Carità, Novara, Italy; Haematology Unit, Department of Internal Medicine, Ospedale degli Infermi, Biella, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12845DOI Listing
July 2014

The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma.

Leuk Lymphoma 2015 Jan 24;56(1):12-25. Epub 2014 Mar 24.

Institute of Hematology and Medical Oncology "L. e A. Seràgnoli", University of Bologna , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.894187DOI Listing
January 2015

The role of myeloablation for lymphoma.

N Engl J Med 2014 02;370(6):574-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1314757DOI Listing
February 2014

Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey.

Leuk Lymphoma 2014 Nov 7;55(11):2564-71. Epub 2014 Mar 7.

Digestive and Liver Disease Department, School of Medicine and Psychology, University "Sapienza", Azienda Ospedaliera S. Andrea , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.879712DOI Listing
November 2014

The risk of CNS involvement in aggressive lymphomas in the rituximab era.

Expert Rev Hematol 2013 Dec 30;6(6):643-52. Epub 2013 Oct 30.

Hematology, Città della Salute e della Scienza Hospital, Corso Bramante 88 10126, Torino, Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/17474086.2013.85
Publisher Site
http://dx.doi.org/10.1586/17474086.2013.850896DOI Listing
December 2013

Extranodal lymphomas.

Rinsho Ketsueki 2013 Oct;54(10):1843-9

Hematology, Città della Salute e della Scienza Hospital.

View Article

Download full-text PDF

Source
October 2013

Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi.

J Clin Oncol 2013 Sep 19;31(27):3351-9. Epub 2013 Aug 19.

Umberto Vitolo, Marco Ladetto, Carola Boccomini, Barbara Botto, Annalisa Chiappella, Andrea Evangelista, Chiara Lobetti-Bodoni, and Giovannino Ciccone, Città della Salute e della Scienza Hospital and University, Turin; Luca Baldini, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico, Università di Milano, Milan; Federico De Angelis, Sapienza University, Rome; Alessandra Tucci and Giuseppe Rossi, Spedali Civili Hospital and University, Brescia; Annalisa Chiarenza, Ferrarotto Hospital, Catania; Antonello Pinto, National Institute for Study and Cure of Tumors, Pascale Foundation; Amalia De Renzo, Federico II University, Napoli; Francesco Zaja, Santa Maria della Misericordia Hospital and University, Udine; Claudia Castellino, Santa Croce and Carle Hospital, Cuneo; Alessia Bari, University of Modena and Reggio Emilia, Modena; Isabel Alvarez De Celis, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia; Guido Parvis, San Luigi Gonzaga Hospital and University, Orbassano; and Enrica Gamba, Roche Italia, Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.8290DOI Listing
September 2013

Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies.

Leuk Lymphoma 2014 May 31;55(5):988-98. Epub 2013 Aug 31.

Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", DISM, Azienda Ospedaliero Universitaria S. M. Misericordia , Udine , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.825903DOI Listing
May 2014

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).

Blood 2013 Aug 10;122(7):1137-43. Epub 2013 Jul 10.

The University of Manchester and Christie National Health Service Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-01-481341DOI Listing
August 2013

XVI. CNS prophylaxis in aggressive lymphomas: for whom and how.

Hematol Oncol 2013 Jun;31 Suppl 1:89-91

Hematology 2, Città della Salute e della Scienza Hospital, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2074DOI Listing
June 2013

Lenalidomide in the treatment of lymphoproliferative disorders and multiple myeloma.

Adv Hematol 2013 16;2013:812605. Epub 2013 Apr 16.

Medical Genetics Unit, University of Perugia, S. Andrea delle Fratte, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/812605DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652128PMC
May 2013

Core binding factor acute myeloid leukaemia and c-KIT mutations.

Oncol Rep 2013 May 5;29(5):1867-72. Epub 2013 Mar 5.

Department of Molecular Biotechnology and Health Sciences, Section of Pathology, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2013.2328DOI Listing
May 2013